Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent

A new layered organic–inorganic nanocomposite material with an anti-parkinsonian active compound, L-3-(3,4-dihydroxyphenyl) alanine (levodopa), intercalated into the inorganic interlayers of a Zn/Al-layered double hydroxide (LDH) was synthesized using a direct coprecipitation method. The resulting n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kura, Aminu Umar, Ali, Samer Hasan Hussein Al, Hussein, Mohd Zobir, Fakurazi, Sharida, Arulselvan, Palanisamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604971/
https://www.ncbi.nlm.nih.gov/pubmed/23524513
http://dx.doi.org/10.2147/IJN.S39740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604971/
https://www.ncbi.nlm.nih.gov/pubmed/23524513
http://dx.doi.org/10.2147/IJN.S39740

Ejemplares similares